335421-04-0

N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99%

N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99%

Catalog No.2463300
Name N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99%
CAS335421-04-0
FormulaC21H20N2O4

Request a Quote

Structure of 335421-04-0

About N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99%

N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99% is a chemical compound registered under CAS number 335421-04-0, with the molecular formula C21H20N2O4 and a molecular weight of about 364.39 g/mol. KingPharm Group supplies N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99% for laboratory research and bulk production; product code 2463300. Send an inquiry for purity, packaging, price and lead time.

CAS Number
335421-04-0
Molecular Formula
C21H20N2O4
Molecular Weight
364.39 g/mol

Related Products

  1. Benzyl 4-bromobenzenecarbodithioate
    305378-89-6
  2. GRAINAL 79
    37286-17-2
  3. N-[2-(trifluoromethyl)phenyl]-4,5-dihydro-1,3-oxazol-2-amine
    33588-19-1
  4. ethyl 3-O-allyl-3,4-dihydroxybenzoate
    305357-41-9
  5. 2-Methoxy-4-[(5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-d]pyrimidin-4-yl)-hydrazonomethyl]-phenol
    304684-77-3
  6. S-ethyl 2-cyano-6-methylquinoline-1(2H)-carbothioate
    40448-83-7
  7. benzoic acid, 2,4-dihydroxy-, [(2,4-dichlorophenyl)methylene]hydrazide
  8. 4-(4-butoxyphenyl)-2-[2-(ethylperoxy)ethyl]-4-methylmorpholin-4-ium bromide
  9. THIAN-4-YLHYDRAZINE HYDROCHLORIDE
  10. [(2-benzamido-4-methylpentanoyl)amino] Benzoate
  11. 335421-04-0 msds
  12. CAS No 335421-04-0 supplier
  13. CASNo 335421-04-0 distributor
  14. CAS # 335421-04-0 manufacturer
  15. CAS Number 335421-04-0 safety
  16. CAS RN 335421-04-0 wholesale
  17. 2026-10-24 Find N-{1-[(2-METHOXYPHENYL)AMINO]-2-(4-METHYLPHENYL)-2 OXOETHYL}FURAN-2-CARBOXAMIDE, 99%,CAS No.335421-04-0,Formula:C21H20N2O4 in KingPharm Group